Stay updated with breaking news from Cell Line Development Workflow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Preliminary SpotLight™ Human Lambda reagent data to be showcased by GSK at the 16th annual PEACe Conference EMERYVILLE, Calif., Sept. 21, 2023 /PRNewswire/ -- PhenomeX Inc. , a functional cell...
Strategic Alternatives Process Continuing; Board Focused on Maximizing Stockholder Value EMERYVILLE, Calif., Aug. 14, 2023 /PRNewswire/ -- PhenomeX, Inc. , a life sciences tools company, today... -Today at 04:06 pm- MarketScreener
/PRNewswire/ -- PhenomeX, Inc. (Nasdaq: CELL), a life sciences tools company, today reported financial results for the second quarter ended June 30, 2023....
/PRNewswire/ -- The "Global Cell Line Development Market Outlook 2031" report has been added to ResearchAndMarkets.com's offering. The global cell line...
Launch of ICON™ and STUDIUS™ – New Products for an Integrated Cell Line Development Workflow, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speakers from Solentim and Galvanize Bio will discuss how data is driving a new workflow for cell line development. They will outline the transparency of clone selection and decision-making during cell line development, as well as integration of automation and software in biotherapeutics. Be the first to learn about two major new products from Solentim in this webinar. Clonality, and the gathering of quality evid...